Stereotactic body radiation therapy versus wedge resection for medically inoperable stage I lung cancer: Tailored therapy or one size fits all?

Journal of Clinical Oncology

Volumn 28, Issue 6, 2010, Pages 905-907

  Altorki, Nasser K ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; DISEASE SEVERITY; EDITORIAL; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; WEDGE RESECTION; CANCER STAGING; LUNG TUMOR; PATHOLOGY; PROGNOSIS; RADIOSURGERY;

HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RADIOSURGERY;

EID: 77949889535     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.26.5157     Document Type: Editorial

References (14)

1. Allen MS, Darling GE, Pechet TT, et al: Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: Initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 81:1013-1019, 2006; discussion 1019-1020
2. National Comprehensive Cancer Network (NCCN), Clinical Practice Guidelines in Oncology. http://www.nccn.org/professionals/physician-gls/PDF/ nscl.pdf
3. El-Sherif A, Gooding WE, Santos R, et al: Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: A 13-year analysis. Ann Thorac Surg 82:408-415, 2006; discussion 415-416
4. Keenan RJ, Landreneau RJ, Maley RH Jr, et al: Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg 78:228-233, 2004; discussion 228-233 (Pubitemid 38833937)
5. Sibley GS: Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma: Smaller volumes and higher doses - A review. Cancer 82:433-438, 1998
6. Zimmermann FB, Geinitz H, Schill S, et al: Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 48:107-114, 2005 (Pubitemid 40381006)
7. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al: Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 75:677-682, 2009
8. Nagata Y, Takayama K, Matsuo Y, et al: Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63:1427-1431, 2005 (Pubitemid 41628038)
9. Onishi H, Shirato H, Nagata Y, et al: Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2:S94-S100, 2007 (suppl 3) (Pubitemid 47183602)
10. Grills IS, Mangona VS, Welsh R, et al: Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer (NSCLC). J Clin Oncol 28:928-935, 2010
11. Ginsberg RJ, Rubinstein LV: Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60:615-622, 1995; discussion 622-623
12. Sienel W, Dango S, Kirschbaum A, et al: Sublobar resections in stage IA non-small cell lung cancer: Segmentectomies result in significantly better cancer-related survival than wedge resections. Eur J Cardiothorac Surg 33:728-734, 2008
13. Birdas TJ, Koehler RP, Colonias A, et al: Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer. Ann Thorac Surg 81:434-438, 2006; discussion 438-439
14. Voynov G, Heron DE, Lin CJ, et al: Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer. Brachytherapy 4:278-285, 2005 (Pubitemid 41774586)